cancer immunotherapy
The convergence of deep neural networks and immunotherapy
What do deep neural networks and cancer immunotherapy have in common?
Immunai raises $60M as it expands from improving immune therapies to discovering new ones, too
Just two years after its founding, biotech startup Immunai has raised $60 million in Series A funding, bringing its total raised to over $80 million. Despite its youth, Immunai has…
Immunai wants to map the entire immune system and raised $20 million in seed funding to do it
For the past two years the founding team of Immunai had been working stealthily to develop a new technology to map the immune system of any patient. Founded by Noam…
Sean Parker’s cancer institute may have found a blood test to see if patients will respond to treatment
Scientists in collaboration with tech billionaire Sean Parker’s Institute for Cancer Immunotherapy may have found a way to predict whether melanoma patients will respond to treatments that target the PD-1…
Sean Parker, the self-made billionaire who, at the tender age of 19, sparked the digital music revolution, has been at the forefront of some of the most meaningful disruptions of…
